Publishing Metrics
Science Advances is prestigious but slow—here's what to expect
Science Advances has a 13.6 impact factor and 25% acceptance rate, but reviewers take 6–9 months. Is it right for your paper? A researcher's breakdown.
Your manuscript looks like it might clear a broad journal: strong mechanism, clean figures, a result that could interest readers outside your subfield. The trap is treating “Science Advances” as a simple prestige upgrade rather than a scheduling decision.
The short answer: Science Advances is a strong AAAS journal, but the current official acceptance signal is closer to 10% than the 25% figure you’ll still see repeated, and the review path can burn most of a year. Submit if the paper is genuinely broad and you can survive the wait.
If the paper is tied to a PhD defense, hiring packet, grant resubmission, or tenure-clock milestone, prestige alone is the wrong variable. Time is the variable.
Why researchers ask if Science Advances is 'good'—and what the answer really depends on
Science Advances is the American Association for the Advancement of Science’s open-access, multidisciplinary journal. It launched as the open-access sibling to Science, which gives it a real brand halo, but it doesn’t behave like a field journal with a narrow editorial audience.
That’s why the “is it good?” question gets messy. Researchers usually mean one of three things: will my department respect it, will the paper get read, or will the process finish before my life becomes administratively painful.
On prestige, the answer is yes. Science Advances sits in the upper tier of broad science journals, and it’s routinely compared with Nature Communications, PNAS, Cell Reports, and the larger open-access titles. For a broader map of where it sits, Otio’s guide to the highest impact factor journals is useful background.
On speed, no. Don’t build a six-month plan around a Science Advances submission unless you’re comfortable being wrong.
On fit, it depends on the paper. A materials science paper with a clean device result and implications across chemistry or physics may travel well. A technically sound neuroscience paper that mostly advances one circuit model may do better in a field-specific venue, even if that venue has a lower headline impact factor.
AAAS also warns against reading journal quality through a single number. Its Science family journal metrics page says the publisher is a DORA signatory and believes a range of metrics should be used to evaluate journal quality. That’s the polite institutional version of the advice your senior coauthor gives you after the third espresso: don’t confuse the journal’s reputation with your paper’s probability of acceptance.
The metrics that matter: impact factor, acceptance rate, and what they actually tell you
The headline metric most people search for is the Science Advances impact factor. Depending on the database and year, you’ll see figures in the low-to-mid teens; the number often cited for recent years is 13.6. That makes it a serious journal, but not the same class of selectivity or cultural force as Science or Nature.
Impact factor measures average citation performance over a defined window. It doesn’t tell you whether your result fits the editorial bar, whether reviewers will demand another animal cohort, or whether the paper will be accepted before your fellowship application closes.
If you’re still using impact factor as a proxy for “good,” read up on what a good impact factor means for a journal. The number only makes sense by field. A 10 in mathematics means something different from a 10 in immunology.
Acceptance rate is where many researchers get misled. You’ll still find estimates around 25% floating around. I wouldn’t plan around that.
A Science Advances editorial article says the journal receives about 20,000 submissions per year and rejects about 90%, mostly without review, according to Science Advances’ “Beating the odds for journal acceptance” essay. A separate 2024 editorial archived by PMC says the journal received more than 21,000 submissions in 2023 and published almost 2,100 papers, according to “A new era at Science Advances”.
~20,000 | ~90% | ~2,100 |
|---|---|---|
annual submissions | rejected overall | papers published in 2023 |
Those figures come from Science Advances’ own editorial commentary and the 2024 PMC-hosted editorial on the journal’s growth.
So, yes, Science Advances is good. It’s also crowded. A 10% effective acceptance environment punishes papers that are merely well executed.
The publication fee is another filter. Science Advances is fully open access, and the article processing charge is commonly listed at $5,500. For a well-funded lab, that’s a budget line. For a postdoc stitching together discretionary funds, it’s a real decision.
Metrics also age. A journal with a high recent impact factor can help early visibility, especially for a paper in a fast-moving area. Long-term canonical status usually comes from the work itself: method adoption, replication, citations in field reviews, and whether other labs build on it.
Exaly’s independent scientometric profile lists Science Advances in the top 1% on several impact measures, including a 2-year impact of 10.9 and 5-year impact of 12.8 in its dataset, according to Exaly’s Science Advances journal profile. Treat that as a useful outside lens, not a substitute for Clarivate’s official Journal Citation Reports.
If you’re comparing citation systems, CiteScore vs. impact factor can change the apparent ranking. Same journal, different denominator. Annoying, but real.
The peer review timeline: expect 6–9 months, not 3
The fastest Science Advances outcome is a desk reject. That sounds bad, but if the answer is no, two to four weeks is kinder than a five-month rejection after reviewer two asks for the experiment you can’t afford.
The slower path begins when the editor sends the paper to outside reviewers. Two reviewers are common. In a narrow subfield, finding reviewers can add weeks before anyone reads page one.
A realistic sequence looks like this:
Stage | What usually happens | Planning assumption |
|---|---|---|
Editorial screening | Scope, novelty, fit for a broad audience | 2–4 weeks |
External review | Reviewers assess claims, methods, framing | 6–9 weeks per round |
Author revision | New analysis, rewritten claims, response letter | 4–6 weeks |
Second look | Editor may return to reviewers | 4–8 weeks |
Final decision | Accept, reject, or another revision | Variable |
Broad peer-review data backs up why this drags. A study of 3,500 review experiences submitted to SciRev analyzed first-round duration, total review duration, rejection timing, reports, revision cycles, and author experience, according to the Springer paper “Duration and quality of the scientific peer review process”. The important bit for planning: peer review varies sharply by field, and multi-month timelines are ordinary.
Science Advances adds another wrinkle: multidisciplinary review. The editor may need one reviewer for the technical core and another for the broader claim. That can improve the paper. It can also produce a maddening review letter where reviewer one says the mechanism is overclaimed and reviewer two says the broader significance needs sharpening.
I’ve watched researchers lose more time after the first review than before it. The review arrives, everyone celebrates because it wasn’t a rejection, then the response letter becomes a 23-page negotiation over one supplementary figure and a sentence in the abstract.
A major revision can still end in rejection. That’s the part early-career authors underprice.
If your paper needs a publication line by a fixed date, count backward from the deadline. A January submission can easily become an April review, a June resubmission, a late-summer second review, and a September decision. Mostly fine for a lab with a publication pipeline. Brutal if it’s the paper your committee keeps asking about.
For practical review mechanics, Otio’s guide on how to peer review a paper efficiently is written from the reviewer side, but authors should read it too. It shows what reviewers notice first when they’re tired, busy, and deciding whether the manuscript earns another hour.
When Science Advances is the right choice—and when it isn't
Choose Science Advances when the paper’s audience is bigger than your field’s weekly seminar. A clean mechanistic advance in one protein family may be excellent science, yet too narrow. A method that changes how several fields measure the same phenomenon has a better shot.
Cross-disciplinary work is the journal’s natural terrain. Physics plus biology. Materials plus energy. Climate modeling with policy-relevant empirical data. The paper still needs technical depth, but the framing can’t assume the reader already cares.
Science Advances is also a good choice when your coauthors can afford patience. That means grant money for the fee, no immediate graduation bottleneck, and a backup plan if the journal says no.
Avoid it when the paper is incremental. “Incremental” isn’t an insult. Most science is incremental, and the record needs those papers. The question is whether an AAAS broad-audience editor can explain your contribution in one crisp sentence to another editor outside your field.
Field fit matters more than junior researchers want it to. A neuroscience paper might get more respect in Nature Neuroscience, Neuron, or a top specialty journal if the audience is mostly neuroscientists. A clinical methods paper may belong in a medical specialty journal, even if the impact factor comparison looks flattering elsewhere.
The NIH’s National Institute of Environmental Health Sciences maintains a page of high impact journals, which is a useful reminder that journal status often gets interpreted through field and funder conventions. Committees don’t read every publishing signal the same way.
If you’re uncertain, build a journal-fit matrix before submitting. Include audience, novelty bar, likely reviewer pool, article fee, average delay risk, and backup journal compatibility. Otio has a separate guide on how to choose the journal for publication, which is the more general version of this decision.
The biggest hidden cost is reformatting after rejection. Science Advances has its own requirements, and the next journal may want a different structure. That sounds clerical until two coauthors disappear to conferences and the resubmission stalls for three weeks.
How to read the acceptance decision: desk reject vs. major revision vs. accept
A desk reject means the editor decided not to send the paper to external reviewers. The usual reasons are fit, scope, novelty, or insufficient interest for a broad Science Advances audience.
Don’t overinterpret the tone. Desk-reject letters are often short because editors are moving through a large submission queue. A polite “not suitable for Science Advances” may hide a dozen possible reasons.
A rejection without review is useful if you treat it as triage. If the paper was aimed too high, resubmit quickly. If the framing failed, rewrite the introduction and significance statement before sending it elsewhere.
Major revision is more complicated. Reviewers saw something worth arguing with. They also found enough uncertainty to slow the paper down.
Read the decision letter before the reviewer comments. Editors often tell you the real path: whether they want a targeted revision, whether a new experiment is expected, or whether the invitation is weak. The phrase “we would be willing to consider” carries less comfort than authors pretend.
Minor revision is rare for a first submission in a competitive journal. When it happens, the core result has survived and the remaining work is usually clarification, figure repair, or text changes. Still, don’t get sloppy. A rushed response letter can irritate a reviewer who was ready to say yes.
Accept on first submission is possible, but don’t build your plan around it. For regular research articles, assume at least one round of revision if the manuscript makes it past review.
The nastiest outcome is rejection after revision. It feels unfair because you already paid the time tax. Yet it happens when reviewers remain unconvinced, the editor loses confidence, or the revision reveals a deeper limitation.
This breaks the moment two reviewers disagree on what “novel” means. One wants broader claims; the other wants narrower language. If the response letter tries to satisfy both by smudging the argument, the editor may decide the paper no longer has a clear center.
A good response letter doesn’t perform obedience. It shows judgment. Concede where the reviewer is right, add analysis where the claim needs support, and push back when a request would turn the paper into a different study.
If you want examples of how reviewers phrase objections, read sample peer reviews of research papers. The pattern recognition helps when you’re drafting your own response.
Three strategies to improve your odds (or avoid the wait entirely)
Start with a preprint if your field permits it. bioRxiv, arXiv, medRxiv, and ChemRxiv give the work a timestamp, expose weak framing before formal review, and let colleagues send the uncomfortable email while changes are still cheap.
Preprints won’t save a paper that lacks novelty. They can reveal whether the claimed audience exists. If nobody outside your group engages, that’s information.
Second, screen the journal’s recent papers before formatting the submission. Pull 10–15 Science Advances articles from the last 12–18 months in your area. Read the abstracts last. Start with the figures, methods depth, and the final paragraph of the introduction.
This is where AI can help if you keep it disciplined. With Otio’s unified PDF library and cited AI chat, you can upload recent Science Advances papers, ask for common novelty claims, compare methods sections, and extract how authors frame significance. Don’t ask whether your paper “belongs.” Ask for a table with claim type, evidence standard, reviewer-sensitive weaknesses, and the sentence each paper uses to justify broad relevance.
The output won’t decide for you. It will make the comparison less vibes-based.
Third, prepare the backup journal before the first decision. Pick Nature Communications, PLOS Biology, Cell Reports, PNAS, or a field journal only after checking scope and audience. Don’t wait until a rejection letter lands to start that conversation.
Without a backup plan | With a backup plan |
|---|---|
Reformat from scratch after rejection | Convert to the next journal’s structure in days |
Debate journal fit while morale is low | Decide fit before reviewer comments arrive |
Let coauthors drift after bad news | Send a revision plan immediately |
Lose a quarter to administrative drag | Keep the paper moving |
Backup planning doesn’t mean you lack confidence. It means the paper matters enough to keep it alive after one editor says no.
For the broader publication sequence, read how to publish a research paper in a journal. The submission mechanics are boring until they cost you a month.
Avoid parallel submission to multiple journals. That violates publishing norms. Parallel preparation is different: one active submission, one ready fallback, no scramble.
Your next move: decide based on timeline, not prestige alone
Science Advances is a good journal by any sensible definition: AAAS backing, broad visibility, strong citation performance, and a large audience across scientific fields. It’s also selective enough that “good paper” isn’t the same as “good bet.”
If you have a year of runway, a result with cross-field relevance, and money for the open-access fee, submit. If the paper is incremental or tied to a hard career deadline, a field-specific journal may be the smarter move.
The best test is simple. Write the broad-audience claim in one sentence. If that sentence sounds inflated, the paper probably isn’t ready for Science Advances.
Use Otio for your Science Advances fit check before you spend a week formatting the submission.
FAQ
Q: Is Science Advances better than Nature Communications?
A: Neither journal is automatically better. Science Advances carries the AAAS brand and broad open-access reach; Nature Communications has its own strong reputation and may fit some life-science papers better. Choose by audience and timeline.
Q: What's the acceptance rate for Science Advances?
A: Don’t rely on the older 25% figure. Science Advances editorial commentary says the journal receives about 20,000 submissions per year and rejects about 90%, which implies an effective acceptance rate around 10%.
Q: How long does peer review take at Science Advances?
A: Plan for 6–9 months from submission to final decision if the paper enters review and needs revision. A desk reject can arrive much faster, often within a few weeks.
Q: Is the $5,500 publication fee worth it?
A: It can be worth it if the paper needs broad open-access visibility and the lab has publishing funds. If the fee strains the project budget, compare field journals and lower-cost open-access options before submitting.
Q: What does 'desk reject' mean, and how can I avoid it?
A: A desk reject means the editor declined the paper without external peer review. Reduce the risk by comparing your manuscript against recent Science Advances papers in your field and tightening the broad-audience novelty claim.
